FindTrial
Sign In

Intensive medical therapy

OTHER3 trials

Sponsors

US Department of Veterans Affairs, Hanyang University, University of Maryland, Baltimore

Conditions

Carotid StenosisIschemic StrokeMetabolic SyndromeMyocardial IschemiaObesityTransient Ischemic Attack

Phase 3

Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation
CompletedNCT00007657
US Department of Veterans AffairsMyocardial Ischemia
Start: 1998-12-31End: 2006-06-30Target: 3260Updated: 2009-06-15

Unknown Phase

Prospective Cohort Study of the Effect of Bariatric/Metabolic Surgery on Morbid Obesity Patients With Metabolic Syndrome
NCT02271568
Hanyang UniversityMetabolic Syndrome, Obesity
Start: 2015-03-31End: 2017-12-31Target: 30Updated: 2016-02-19
Symptomatic Carotid Outcomes Registry
Active, not recruitingNCT05300737
University of Maryland, BaltimoreCarotid Stenosis, Ischemic Stroke, Transient Ischemic Attack
Start: 2022-08-01End: 2026-12-31Target: 114Updated: 2025-10-17

Related Papers

Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes.
2019-04-0123 citations
Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart Disease
Circulation Cardiovascular Quality and Outcomes2019-02-0135 citations
Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial.
2018-11-0130 citations
Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease
Circulation Cardiovascular Quality and Outcomes2018-05-0125 citations
Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease
New England Journal of Medicine2015-11-11287 citations
Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia.
2014-01-15158 citations
Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
2013-08-2171 citations
Frequency, Predictors, and Consequences of Crossing Over to Revascularization Within 12 Months of Randomization to Optimal Medical Therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial
Circulation Cardiovascular Quality and Outcomes2013-07-0137 citations
Risk factor control for coronary artery disease secondary prevention in large randomized trials.
2013-04-01104 citations
Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial.
2011-07-0134 citations
The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable angina.
2011-02-0815 citations
Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial.
2010-03-0173 citations
Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
2009-09-0140 citations
Effect of PCI on quality of life in patients with stable coronary disease.
2008-08-01466 citations
Optimal medical therapy with or without PCI for stable coronary disease.
2007-03-262887 citations